Raily Aesthetic Medicine International Holdings Limited (HKG:2135)

HKG:2135 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	35.73	28.87	39.79	78.78	121.72	158.9
Short-Term Investments	-	-	-	-	3.17	6.5
Cash & Short-Term Investments	35.73	28.87	39.79	78.78	124.89	165.39
Cash Growth	-12.54%	-27.44%	-49.49%	-36.92%	-24.49%	207.15%
Accounts Receivable	0.72	1.54	9.5	5.34	6.09	5.13
Other Receivables	-	-	-	0.68	1.09	0.59
Receivables	0.72	1.54	9.5	6.02	7.19	5.72
Inventory	8.64	14.37	11.44	13.55	14.12	11.62
Prepaid Expenses	-	-	-	2.14	1.92	4.66
Other Current Assets	37.91	45.66	18.89	12.07	2.9	4.22
Total Current Assets	83.14	90.43	79.62	112.56	151.02	191.61
Property, Plant & Equipment	83.84	78.32	94.63	84.01	80.06	44.2
Long-Term Investments	1.07	1.13	0.71	3.26	3.35	5.93
Goodwill	6.15	6.15	44.82	56.76	63.13	20.21
Other Intangible Assets	42.2	43.91	23.82	30.47	34.01	5.04
Long-Term Deferred Tax Assets	8.73	10	9.4	12.72	11.43	5.35
Other Long-Term Assets	15.76	19.99	20.61	2.88	1.74	-
Total Assets	240.89	249.92	273.6	302.65	344.73	272.33
Accounts Payable	7.7	7.78	9.5	9.17	12.57	12.16
Accrued Expenses	0.25	-	-	6.94	8.51	7.14
Short-Term Debt	-	17.28	7	5	20	13
Current Portion of Leases	30.04	12.23	10.34	8.67	7.76	5.08
Current Income Taxes Payable	5.99	9.66	6.9	7.48	7.3	10.45
Current Unearned Revenue	35.09	38.83	20.98	16.61	14.69	8.01
Other Current Liabilities	26.75	37.82	37.44	22.55	44.48	15.64
Total Current Liabilities	130.28	123.59	92.16	76.41	115.3	71.47
Long-Term Debt	1.2	3.47	-	-	-	-
Long-Term Leases	17.27	23.39	34.44	34.56	39.69	14.11
Long-Term Deferred Tax Liabilities	-	-	5.88	6.63	7.38	-
Other Long-Term Liabilities	3.82	3.96	8.53	19.18	-	-
Total Liabilities	152.57	154.41	141.01	136.77	162.37	85.58
Common Stock	185.75	185.75	136.27	136.27	136.27	134.06
Retained Earnings	-	-98.9	-36.24	-3.78	12.13	29.85
Comprehensive Income & Other	-87.77	17.28	38.09	33.6	29.83	21.96
Total Common Equity	97.97	104.13	138.12	166.08	178.22	185.87
Minority Interest	-9.66	-8.62	-5.53	-0.2	4.13	0.88
Shareholders' Equity	88.32	95.52	132.59	165.88	182.35	186.75
Total Liabilities & Equity	240.89	249.92	273.6	302.65	344.73	272.33
Total Debt	72.96	56.37	51.78	48.22	67.45	32.19
Net Cash (Debt)	-37.23	-27.5	-11.99	30.56	57.44	133.21
Net Cash Growth	-	-	-	-46.80%	-56.88%	549.32%
Net Cash Per Share	-0.07	-0.05	-0.03	0.07	0.14	0.39
Filing Date Shares Outstanding	557.08	557.08	417.81	417.81	417.81	417.81
Total Common Shares Outstanding	557.08	557.08	417.81	417.81	417.81	411
Working Capital	-47.14	-33.15	-12.54	36.15	35.71	120.14
Book Value Per Share	0.18	0.19	0.33	0.40	0.43	0.45
Tangible Book Value	49.63	54.08	69.47	78.85	81.08	160.62
Tangible Book Value Per Share	0.09	0.10	0.17	0.19	0.19	0.39
Machinery	-	41.83	48.44	48.22	45.8	42.82
Construction In Progress	-	20.61	17.43	2.72	1.49	-
Leasehold Improvements	-	37.47	41.33	36.15	21.56	12.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.